Lymphangioleiomyomatosis (LAM) Market - Top Companies and Manufacturers

  • Report ID: 2701
  • Published Date: Oct 17, 2024
  • Report Format: PDF, PPT

Companies Dominating the Lymphangioleiomyomatosis (LAM) Landscape

    • Pfizer Inc. 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Zydus Pharmaceuticals, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Apotex Inc.
    • Amneal Pharmaceuticals LLC.
    • Teva Pharmaceutical Industries Ltd.
    • Torrent Pharmaceuticals Ltd.
    • Intas Pharmaceuticals Ltd.
    • AstraZeneca
    • AI Therapeutics, Inc.

     


Browse Key Market Insights with Data Illustration:

In the News

  • January 7, 2020: AI Therapeutics, a clinical-stage biopharmaceutical company, announced substantial progress on two of their programs - LAM-001, world’s first inhaled formulation of rapamycin that would be studied in clinical trials and LAM-004, which has finished a Phase 1 trial in patients having facial angiofibroma.

  • January 16, 2020: AI Therapeutics announced that their LAM-002 has received Fast Track status and Orphan Drug Designation from the U.S. FDA for Pivotal Trial Design of the treatment of follicular lymphoma.


Author Credits:  Radhika Pawar


  • Report ID: 2701
  • Published Date: Oct 17, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of lymphangioleiomyomatosis is estimated at USD 133.86 million.

Lymphangioleiomyomatosis (LAM) Market size was over USD 128.91 million in 2023 and is anticipated to cross USD 237.13 million by 2036, growing at more than 4.8% CAGR during the forecast period i.e., between 2024-2036.

North America industry is likely to account for largest revenue share by 2036, attributed to factors such as high healthcare spending, a high rate of adoption of technologies, a rise in the prevalence of lifestyle-related disorders, and a promising pipeline.

The major players in the market are Pfizer Inc., Zydus Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Amneal Pharmaceuticals LLC., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., AstraZeneca, AI Therapeutics, Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample